Insider trades

Gheuens Sarah, Chief Officer of Agios Pharmaceuticals AGIO, has filed 0 purchases and 22 sales on the open market. Over the past 12 months that comes to a net sale of $560.1K. The latest trade was on 06/18.

Gheuens Sarah

Chief Medical Officer
First filing
23/03/03
Trades
85 trades
Buys / sales
0 / 22
12-month net buying
−$560.1K
Last trade
06/18

Trading activity

Transactions

Trade type
Open-market sale10b5-1 plan04/0204/062,940 sh$34.71$102,047.4−3.5%
AGIO
Open-market sale10b5-1 plan03/0203/034,055 sh3 trades$28.96avg.$117,432.8−5.2%
Open-market sale10b5-1 plan25/12/3001/022,932 sh$27.09$79,427.88−4.3%
Open-market sale10b5-1 plan25/11/1125/11/132,454 sh$43.78$107,436.12−3.8%
Open-market sale10b5-1 plan25/10/3025/11/03200 sh$43.81$8,762−0.3%
Open-market sale10b5-1 plan25/10/2725/10/293,302 sh$43.92$145,023.84−5.1%
AGIO
Open-market sale10b5-1 plan25/07/0925/07/1111,914 sh2 trades$37.99avg.$452,601.03−16.3%
Open-market sale10b5-1 plan25/07/0125/07/034,091 sh$34.17$139,789.47−6.3%
Open-market sale10b5-1 plan25/06/2425/06/262,909 sh$33.54$97,567.86−4.9%
AGIO
Open-market sale10b5-1 plan25/03/0325/03/044,005 sh3 trades$35.54avg.$142,337.7−6.9%
Open-market sale10b5-1 plan24/07/0124/07/033,705 sh$43.85$162,464.25−7.8%
AGIO
Open-market sale10b5-1 plan24/03/0524/03/052,642 sh2 trades$32.57avg.$86,049.94−6.3%
Open-market sale10b5-1 plan24/02/1424/02/14642 sh$25.14$16,139.88−1.9%
Open-market sale10b5-1 plan24/01/2424/01/241,708 sh$21.64$36,961.12−5.1%
Open-market sale10b5-1 plan24/01/0924/01/091,789 sh$22.99$41,129.11−6.0%
Open-market sale10b5-1 plan23/06/3023/06/301,707 sh$28.36$48,410.52−6.6%